Boeing price target raised to $200 from $190 at JPMorgan
JPMorgan analyst Seth Seifman raised the firm’s price target on Boeing (BA) to $200 from $190 and keeps an Overweight rating on the shares, ...
Morgan Stanley maintains $200 target on Sarepta Therapeutics stock
Morgan Stanley (NYSE:MS) reaffirmed its Overweight rating on Sarepta Therapeutics (NASDAQ:SRPT), an $11.27 billion market cap biotechnology company, with a steady price target of $200.00. The ...